TGTX TG Therapeutics Inc

USD 35.07 0.00 ( 0.00)%
Icon

TG Therapeutics Inc (TGTX) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 35.07

0.00 (0.00)%

USD 4.48B

2.58M

USD 42.25(+20.47%)

USD 5.90 (-83.18%)

Icon

TGTX

TG Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 35.07
0.00 ( 0.00)%
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 4.48B

USD 5.90 (-83.18%)

USD 35.07

TG Therapeutics Inc (TGTX) Stock Forecast

Show ratings and price targets of :
USD 42.25
(+20.47%)

Based on the TG Therapeutics Inc stock forecast from 5 analysts, the average analyst target price for TG Therapeutics Inc is USD 42.25 over the next 12 months. TG Therapeutics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of TG Therapeutics Inc is Slightly Bullish , which is based on 9 positive signals and 6 negative signals. At the last closing, TG Therapeutics Inc’s stock price was USD 35.07. TG Therapeutics Inc’s stock price has changed by +18.72% over the past week, +51.03% over the past month and +174.20% over the last year.

No recent analyst target price found for TG Therapeutics Inc
No recent average analyst rating found for TG Therapeutics Inc

Company Overview TG Therapeutics Inc

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. It provides BRIUMVI, an anti-CD20 monoclonal antibody for...Read More

3020 Carrington Mill Blvd., Morrisville, NC, United States, 27560

264

December

USD

USA

Adjusted Closing Price for TG Therapeutics Inc (TGTX)

Loading...

Unadjusted Closing Price for TG Therapeutics Inc (TGTX)

Loading...

Share Trading Volume for TG Therapeutics Inc Shares

Loading...

Compare Performance of TG Therapeutics Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for TGTX

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To TG Therapeutics Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc 0.00 (0.00%) USD115.98B 32.57 215.15

Frequently Asked Questions About TG Therapeutics Inc (TGTX) Stock

Based on ratings from 5 analysts TG Therapeutics Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 7 buy, sell and 1 hold ratings.

Unfortunately we do not have enough data on TGTX's stock to indicate if its a good dividend stock.

Based on targets from 5 analysts, the average taret price for TGTX is USD 42.25 over the next 12 months. The maximum analyst target price is USD 55 while the minimum anlayst target price is USD 20.

TGTX stock's Price/Earning ratio is 34.35. Our analysis grades TGTX stock's Price / Earning ratio at F. This means that TGTX stock's Price/Earning ratio is above 80% of the stocks in the Biotechnology sector in the NSD exchange. Based on this TGTX may be a overvalued for its sector.

The last closing price of TGTX's stock was USD 35.07.

The most recent market capitalization for TGTX is USD 4.48B.

Based on targets from 5 analysts, the average taret price for TGTX is projected at USD 42.25 over the next 12 months. This means that TGTX's stock price may go up by +20.47% over the next 12 months.

We can't find any ETFs which contains TG Therapeutics Inc's stock.

As per our most recent records TG Therapeutics Inc has 264 Employees.

TG Therapeutics Inc's registered address is 3020 Carrington Mill Blvd., Morrisville, NC, United States, 27560. You can get more information about it from TG Therapeutics Inc's website at https://www.tgtherapeutics.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About TG Therapeutics Inc (TGTX) Stock

Based on ratings from 5 analysts TG Therapeutics Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 7 buy, sell and 1 hold ratings.

Unfortunately we do not have enough data on TGTX's stock to indicate if its a good dividend stock.

Based on targets from 5 analysts, the average taret price for TGTX is USD 42.25 over the next 12 months. The maximum analyst target price is USD 55 while the minimum anlayst target price is USD 20.

TGTX stock's Price/Earning ratio is 34.35. Our analysis grades TGTX stock's Price / Earning ratio at F. This means that TGTX stock's Price/Earning ratio is above 80% of the stocks in the Biotechnology sector in the NSD exchange. Based on this TGTX may be a overvalued for its sector.

The last closing price of TGTX's stock was USD 35.07.

The most recent market capitalization for TGTX is USD 4.48B.

Based on targets from 5 analysts, the average taret price for TGTX is projected at USD 42.25 over the next 12 months. This means that TGTX's stock price may go up by +20.47% over the next 12 months.

We can't find any ETFs which contains TG Therapeutics Inc's stock.

As per our most recent records TG Therapeutics Inc has 264 Employees.

TG Therapeutics Inc's registered address is 3020 Carrington Mill Blvd., Morrisville, NC, United States, 27560. You can get more information about it from TG Therapeutics Inc's website at https://www.tgtherapeutics.com.
Loading...